Thomas M. Ross's most recent trade in MaxCyte Inc was a trade of 17,857 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 17,857 | 1 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 17,857 | 25,000 | - | 4.4 | 77,874 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 17,857 | 42,857 | - | 1.6 | 29,303 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 15,476 | 40,476 | - | 1.6 | 25,396 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 15,476 | 17,858 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 01 Aug 2024 | 15,476 | 25,000 | - | 4.5 | 70,261 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 19,802 | 46,865 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 19,802 | 25,000 | - | 4.0 | 79,782 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 19,802 | 44,802 | - | 1.6 | 32,495 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 13,531 | 25,000 | - | 4.0 | 54,584 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 13,531 | 38,531 | - | 1.6 | 22,204 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 08 Jul 2024 | 13,531 | 33,334 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 20 Jun 2024 | 33,333 | 66,667 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 20 Jun 2024 | 33,333 | 25,000 | - | 4.1 | 136,465 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES | 20 Jun 2024 | 33,333 | 58,333 | - | 1.6 | 54,699 | Common Stock | |
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES & MARKETING | 15 Mar 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Thomas M. Ross | EVP, GLOBAL SALES & MARKETING | 15 Mar 2024 | 25,000 | 25,000 | - | 0 | Common Stock |